VLC
TMO icon

Van Leeuwen & Company’s Thermo Fisher Scientific TMO Stock Holding History

Van Leeuwen & Company’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,602
Closed -$1.35M – 87
2023
Q2 		$1.35M Sell
2,602
-2,098
-45% -$1.13M 0.85% 36
2023
Q1 		$2.71M Buy
+4,700
New +$2.65M 1.82% 20

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Van Leeuwen & Company's TMO Position: Q3 2023 in Review

Van Leeuwen & Company sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 2,602 shares — an estimated $1.35M sold.

Van Leeuwen & Company first reported a position in TMO in Q1 2023 and held it in 2 quarters. The position peaked at $2.71M in Q1 2023. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Van Leeuwen & Company reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Van Leeuwen & Company sold 2,602 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.35M.
  • Van Leeuwen & Company first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 2 quarters.
  • Van Leeuwen & Company's Thermo Fisher Scientific position peaked at $2.71M in Q1 2023.
  • 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Van Leeuwen & Company's 13F filing for Q3 2023, filed 9 Nov 2023.